HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gregory A Otterson Selected Research
Gregory A Otterson Research Topics
Disease
65
Neoplasms (Cancer)
01/2022 - 06/2002
46
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2003
22
Lung Neoplasms (Lung Cancer)
01/2022 - 04/2003
7
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 03/2010
6
Neutropenia
10/2016 - 04/2006
6
Leukemia
05/2015 - 05/2004
5
Diarrhea
10/2019 - 06/2002
5
Fatigue
10/2016 - 04/2006
4
Thrombocytopenia (Thrombopenia)
10/2016 - 09/2004
3
Neoplasm Metastasis (Metastasis)
01/2021 - 01/2013
3
Adenocarcinoma
01/2018 - 01/2015
3
Nausea
03/2016 - 11/2010
3
Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 06/2002
3
Malignant Mesothelioma
06/2012 - 05/2004
2
Exanthema (Rash)
01/2022 - 11/2010
2
Cachexia
01/2022 - 04/2006
2
Pneumonia (Pneumonitis)
11/2020 - 11/2018
2
Fanconi Anemia (Fanconi's Anemia)
01/2019 - 01/2016
2
Disease Progression
05/2018 - 03/2010
2
Brain Neoplasms (Brain Tumor)
02/2017 - 07/2016
2
Anemia
10/2016 - 11/2010
2
Dehydration (Water Stress)
10/2016 - 01/2010
2
Vomiting
03/2016 - 11/2010
2
Febrile Neutropenia
03/2016 - 11/2010
2
Hemorrhage
05/2015 - 06/2012
2
Sarcoma (Soft Tissue Sarcoma)
03/2014 - 02/2007
2
Hematologic Neoplasms (Hematological Malignancy)
08/2011 - 08/2009
2
Carcinogenesis
08/2009 - 11/2002
1
Melanoma (Melanoma, Malignant)
01/2021
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2020
1
Colitis
10/2019
Drug/Important Bio-Agent (IBA)
12
Immune Checkpoint Inhibitors
IBA
01/2022 - 03/2015
10
Nivolumab
IBA
01/2022 - 03/2015
10
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 04/2003
9
Docetaxel (Taxotere)
FDA Link
10/2019 - 06/2002
8
Biomarkers (Surrogate Marker)
IBA
01/2020 - 06/2012
7
Carboplatin (JM8)
FDA Link
Generic
01/2019 - 08/2003
7
ErbB Receptors (EGF Receptor)
IBA
11/2018 - 09/2014
7
Proteins (Proteins, Gene)
FDA Link
11/2016 - 11/2004
6
B7-H1 Antigen
IBA
01/2022 - 11/2016
5
Ipilimumab
IBA
01/2022 - 05/2018
5
Tyrosine Kinase Inhibitors
IBA
01/2019 - 12/2010
5
Histone Deacetylase Inhibitors
IBA
12/2017 - 05/2003
5
Bevacizumab (Avastin)
FDA Link
11/2016 - 12/2010
5
Cisplatin (Platino)
FDA Link
Generic
05/2015 - 09/2004
5
Gemcitabine
FDA Link
06/2013 - 09/2004
4
Platinum
IBA
01/2018 - 04/2010
4
Formaldehyde (Formol)
FDA Link
09/2017 - 03/2013
4
Paclitaxel (Taxol)
FDA Link
Generic
03/2016 - 08/2003
4
Smoke
IBA
09/2014 - 07/2009
4
Capecitabine (Xeloda)
FDA Link
01/2013 - 06/2002
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022 - 05/2020
3
Histones (Histone)
IBA
01/2021 - 03/2006
3
Messenger RNA (mRNA)
IBA
01/2021 - 12/2013
3
Antibodies
IBA
01/2020 - 03/2013
3
Crizotinib
IBA
01/2020 - 01/2013
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2017 - 05/2011
3
Pemetrexed (MTA)
FDA Link
11/2015 - 01/2013
3
Paraffin
IBA
05/2014 - 03/2013
3
romidepsin (FK228)
FDA Link
08/2011 - 05/2003
3
Suramin (Suramin Sodium)
IBA
11/2010 - 08/2003
3
MicroRNAs (MicroRNA)
IBA
07/2010 - 08/2009
2
Albumins
IBA
01/2022 - 11/2015
2
pembrolizumab
IBA
01/2021 - 01/2020
2
130-nm albumin-bound paclitaxel
IBA
01/2019 - 11/2015
2
rociletinib
IBA
11/2018 - 10/2016
2
Methyltransferases
IBA
12/2017 - 05/2003
2
Vorinostat
FDA Link
12/2017 - 05/2003
2
Angiogenesis Inhibitors
IBA
11/2016 - 12/2010
2
Phosphotransferases (Kinase)
IBA
11/2016 - 06/2003
2
Alanine Transaminase (SGPT)
IBA
10/2016 - 06/2012
2
Electrolytes
IBA
03/2016 - 11/2010
2
Etoposide (VP 16)
FDA Link
Generic
05/2015 - 06/2003
2
Sunitinib (Sutent)
FDA Link
05/2015 - 02/2014
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)
IBA
06/2013 - 11/2012
2
Dasatinib (BMS 354825)
FDA Link
04/2012 - 03/2010
2
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2010 - 02/2007
2
Enzymes
IBA
11/2009 - 06/2002
2
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
10/2006 - 11/2004
2
Thymidine Phosphorylase
IBA
03/2005 - 06/2002
1
Cell-Free Nucleic Acids
IBA
01/2021
1
Untranslated RNA (Noncoding RNA)
IBA
01/2021
1
Temozolomide (Temodar)
FDA Link
Generic
01/2021
1
Ligands
IBA
12/2020
1
Anti-Bacterial Agents (Antibiotics)
IBA
05/2020
1
Lactams
IBA
05/2020
1
Antigens
IBA
01/2020
1
Circulating Tumor DNA
IBA
01/2020
1
Agglutinins
IBA
01/2020
1
entrectinib
IBA
01/2020
1
Codon (Codons)
IBA
11/2019
1
Insulin-Like Growth Factor I (IGF-1)
IBA
01/2019
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2019
1
Biological Products
IBA
01/2019
1
Antineoplastic Agents (Antineoplastics)
IBA
12/2017
Therapy/Procedure
32
Therapeutics
01/2022 - 04/2006
18
Drug Therapy (Chemotherapy)
01/2022 - 06/2002
7
Immunotherapy
01/2022 - 01/2017
6
Radiotherapy
11/2018 - 12/2014
1
Aftercare (After-Treatment)
01/2020